Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Roggi

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Epidemiology|April 15, 2014
Extensively drug-resistant tuberculosis: epidemiology and managementAlberto Matteelli, Alberto Roggi, Anna Cc Carvalho
Mediterranean Journal of Hematology and Infectious Diseases|November 20, 2014
Tuberculosis: epidemiology and controlGiorgia Sulis, Alberto Roggi, Alberto Matteelli, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|July 16, 2011
Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, ItalyMaria Grazia Cusi, Alberto Roggi, Chiara Terrosi, et al.
Journal of Clinical Medicine|June 21, 2020
Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in BurundiFrançois Ciza, Tinne Gils, Michel Sawadogo, et al.
International Health|April 23, 2026
Feasibility and outcomes of diabetes mellitus screening in people with tuberculosis in BurundiFrançois Ciza, Michel Sawadogo, Josélyne Nsanzerugeze, et al.
Emerging Infectious Diseases|October 22, 2015
Mycobacterium sherrisii Pulmonary Disease, Burkina FasoEmanuele Borroni, Gisèle Badoum, Daniela M Cirillo, et al.
BMC Infectious Diseases|June 28, 2020
Pharmacokinetic study of two different rifabutin doses co-administered with lopinavir/ritonavir in African HIV and tuberculosis co-infected adult patientsSeni Kouanda, Henri Gautier Ouedraogo, Kadari Cisse, et al.
Annals of Clinical Microbiology and Antimicrobials|January 24, 2020
Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis-HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per weekHenri Gautier Ouedraogo, Alberto Matteelli, Giorgia Sulis, et al.
The European Respiratory Journal|July 25, 2020
High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing lossMahamadou Bassirou Souleymane, Alberto Piubello, Ibrahim Mamane Lawan, et al.
Respiratory Medicine|February 15, 2020
Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievementsAlberto Piubello, Mahamadou Bassirou Souleymane, Souleymane Hassane-Harouna, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Epidemiology|April 15, 2014
Extensively drug-resistant tuberculosis: epidemiology and managementAlberto Matteelli, Alberto Roggi, Anna Cc Carvalho
Mediterranean Journal of Hematology and Infectious Diseases|November 20, 2014
Tuberculosis: epidemiology and controlGiorgia Sulis, Alberto Roggi, Alberto Matteelli, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|July 16, 2011
Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, ItalyMaria Grazia Cusi, Alberto Roggi, Chiara Terrosi, et al.
Journal of Clinical Medicine|June 21, 2020
Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in BurundiFrançois Ciza, Tinne Gils, Michel Sawadogo, et al.
International Health|April 23, 2026
Feasibility and outcomes of diabetes mellitus screening in people with tuberculosis in BurundiFrançois Ciza, Michel Sawadogo, Josélyne Nsanzerugeze, et al.
Emerging Infectious Diseases|October 22, 2015
Mycobacterium sherrisii Pulmonary Disease, Burkina FasoEmanuele Borroni, Gisèle Badoum, Daniela M Cirillo, et al.
BMC Infectious Diseases|June 28, 2020
Pharmacokinetic study of two different rifabutin doses co-administered with lopinavir/ritonavir in African HIV and tuberculosis co-infected adult patientsSeni Kouanda, Henri Gautier Ouedraogo, Kadari Cisse, et al.
Annals of Clinical Microbiology and Antimicrobials|January 24, 2020
Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis-HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per weekHenri Gautier Ouedraogo, Alberto Matteelli, Giorgia Sulis, et al.
The European Respiratory Journal|July 25, 2020
High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing lossMahamadou Bassirou Souleymane, Alberto Piubello, Ibrahim Mamane Lawan, et al.
Respiratory Medicine|February 15, 2020
Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievementsAlberto Piubello, Mahamadou Bassirou Souleymane, Souleymane Hassane-Harouna, et al.
Pageof 1